Medicare Enrolled
Dr. Justin Favaro, MD
Hematology & Oncology · Charlotte, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Favaro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Favaro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Favaro
Dr. Justin Favaro is a hematology & oncology specialist in Charlotte, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Favaro performed 73,171 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Favaro received a total of $29,422 from 100 pharmaceutical and/or device companies across 709 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Favaro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in NC
$29,422 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗73,171
Medicare services
Top 3% in NC for hematology & oncology
Not available
Unique patients (not deduplicated)
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
20,400 | $2 | $8 |
| Denosumab injection (Prolia/Xgeva) | 14,040 | $18 | $38 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
11,366 | $36 | $85 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
5,000 | $6 | $25 |
| Iron infusion (Monoferric) | 4,700 | $17 | $50 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
3,900 | $0 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,368 | $8 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,050 | $8 | $15 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,852 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,795 | $93 | $220 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
599 | $10 | $38 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
458 | $10 | $24 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
445 | $11 | $40 |
| Anti-nausea injection (Aloxi/palonosetron) | 390 | $1 | $45 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
301 | $94 | $268 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
294 | $2 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
283 | $133 | $300 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
281 | $47 | $181 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
278 | $45 | $138 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
265 | $1 | $5 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
233 | $15 | $42 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
227 | $2 | $5 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
200 | $24 | $100 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
130 | $52 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
125 | $61 | $150 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
119 | $3 | $7 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
105 | $21 | $60 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
104 | $1 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
103 | $20 | $60 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
86 | $48 | $130 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
74 | $1 | $25 |
| New patient office visit, complex (60-74 min) | 68 | $162 | $410 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
67 | $24 | $70 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
64 | $92 | $210 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
55 | $61 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $119 | $320 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
50 | $6 | $13 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 45 | $366 | $1,390 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
39 | $8 | $19 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
36 | $17 | $50 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
32 | $62 | $200 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
30 | $10 | $30 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
25 | $36 | $137 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $27 | $90 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
15 | $38 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
23.9% high complexity
65.1% medium
11.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,422
Total received (2018-2024)
Avg $4,203/year across 7 years
Top 14% in NC for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
100
Companies
709
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,084
2023
$3,710
2022
$5,267
2021
$5,037
2020
$2,085
2019
$2,569
2018
$2,669
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$3,440
AstraZeneca Pharmaceuticals LP
$1,215
Astellas Pharma US Inc
$397
Janssen Biotech, Inc.
$380
PFIZER INC.
$370
Novartis Pharmaceuticals Corporation
$294
Merck Sharp & Dohme LLC
$201
Celgene Corporation
$171
SOBI, INC
$149
Pharmacosmos Therapeutics Inc.
$133
Daiichi Sankyo Inc.
$102
ARRAY BIOPHARMA INC
$98
Genentech USA, Inc.
$96
ASD Specialty Healthcare, LLC
$78
GlaxoSmithKline, LLC.
$75
Genmab U.S., Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$64
Adaptive Biotechnologies Corporation
$63
Exelixis Inc.
$53
ADC Therapeutics America, Inc.
$45
Gilead Sciences, Inc.
$43
Lilly USA, LLC
$42
SERVIER PHARMACEUTICALS LLC
$42
Eisai Inc.
$41
Aveo Pharmaceuticals, Inc.
$38
ABBVIE INC.
$36
GENZYME CORPORATION
$29
Deciphera Pharmaceuticals Inc.
$29
Incyte Corporation
$28
Alexion Pharmaceuticals, Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Fresenius Kabi USA, LLC
$27
Bayer Healthcare Pharmaceuticals Inc.
$25
SpringWorks Therapeutics, Inc.
$24
Karyopharm Therapeutics Inc.
$23
Tactile Systems Technology Inc
$22
Janssen Pharmaceuticals, Inc
$19
SHIELD THERAPEUTICS INC
$17
Bard Peripheral Vascular, Inc.
$14
MorphoSys, US Inc.
$14
Coherus Biosciences Inc.
$14
Amgen Inc.
$14
Top 3 companies account for 62.5% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$4,337
AstraZeneca Pharmaceuticals LP
$2,751
GENZYME CORPORATION
$2,547
Genentech USA, Inc.
$2,302
Laboratory Corporation of America Holdings
$1,932
Fresenius Kabi USA, LLC
$1,777
Novartis Pharmaceuticals Corporation
$973
PFIZER INC.
$837
Epizyme, Inc.,
$735
Janssen Biotech, Inc.
$686
Astellas Pharma US Inc
$649
Amgen Inc.
$458
Celgene Corporation
$412
Lilly USA, LLC
$401
Merck Sharp & Dohme LLC
$382
Secura Bio, Inc.
$362
Seattle Genetics, Inc.
$357
Incyte Corporation
$328
Merck Sharp & Dohme Corporation
$303
ASD Specialty Healthcare, LLC
$302
Foundation Medicine, Inc.
$260
Daiichi Sankyo Inc.
$256
Exelixis Inc.
$219
CTI BioPharma Corp.
$214
JAZZ PHARMACEUTICALS INC.
$208
Takeda Pharmaceuticals U.S.A., Inc.
$195
Seagen Inc.
$192
GlaxoSmithKline, LLC.
$191
Ipsen Biopharmaceuticals, Inc
$174
ABBVIE INC.
$168
ARRAY BIOPHARMA INC
$166
Gilead Sciences, Inc.
$166
Pharmacosmos Therapeutics Inc.
$164
Novocure Inc.
$162
Eisai Inc.
$160
Karyopharm Therapeutics Inc.
$157
SOBI, INC
$149
EMD Serono, Inc.
$136
ASD SPECIALTY HEALTHCARE, LLC
$136
ADC Therapeutics America, Inc.
$134
EISAI INC.
$133
AngioDynamics, Inc.
$129
Sobi, Inc
$123
Bayer HealthCare Pharmaceuticals Inc.
$121
Taiho Oncology, Inc.
$110
SANOFI-AVENTIS U.S. LLC
$106
SERVIER PHARMACEUTICALS LLC
$100
Pharmacyclics LLC, An AbbVie Company
$97
Heron Therapeutics, Inc.
$92
Alexion Pharmaceuticals, Inc.
$90
Bayer Healthcare Pharmaceuticals Inc.
$79
Janssen Pharmaceuticals, Inc
$79
IntrinsiQ Specialty Solutions, Inc.
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
Deciphera Pharmaceuticals Inc.
$77
MorphoSys, US Inc.
$73
Janssen Scientific Affairs, LLC
$69
Genmab U.S., Inc.
$65
Adaptive Biotechnologies Corporation
$63
Alnylam Pharmaceuticals Inc.
$58
AbbVie, Inc.
$57
Aveo Pharmaceuticals, Inc.
$57
Genentech, Inc.
$55
Regeneron Healthcare Solutions, Inc.
$54
BeiGene USA, Inc.
$53
Spectrum Pharmaceuticals Inc.
$51
Stemline Therapeutics Inc.
$46
Kyowa Kirin, Inc.
$45
Mylan Institutional Inc.
$40
Organon LLC
$38
Verastem, Inc.
$37
Agios Pharmaceuticals, Inc.
$36
Octapharma USA, Inc.
$36
Coherus Biosciences Inc.
$35
GE HealthCare
$34
TerSera Therapeutics LLC
$33
NOVARTIS PHARMACEUTICALS CORPORATION
$32
RECORDATI_RARE_DISEASES_INC.
$26
AbbVie Inc.
$25
SpringWorks Therapeutics, Inc.
$24
PharmaEssentia USA Corporation
$24
Progenics Pharmaceuticals, Inc.
$24
TG Therapeutics, Inc.
$23
Tactile Systems Technology Inc
$22
TG THERAPEUTICS, INC.
$22
AVEO Pharmaceuticals, Inc.
$19
Kite Pharma, Inc.
$19
TESARO, Inc.
$18
Mirati Therapeutics, Inc.
$17
SHIELD THERAPEUTICS INC
$17
Global Blood Therapeutics, Inc.
$16
Dova Pharmaceuticals
$16
Helsinn Therapeutics (U.S.), Inc.
$15
AMAG Pharmaceuticals, Inc.
$15
Puma Biotechnology, Inc.
$15
Pharmacyclics LLC, an AbbVie Company
$15
Bard Peripheral Vascular, Inc.
$14
Shield Therapeutics Inc
$13
Rigel Pharmaceuticals, Inc.
$12
Lexicon Pharmaceuticals, Inc.
$12
Top 3 companies account for 32.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AUGTYRO · Abraxane · Alecensa · Aliqopa · Avastin · BALVERSA · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CERDELGA · CINVANTI · CYRAMZA · Cabometyx · Copiktra · DALVANCE · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · EPKINLY · ERLEADA · EVENITY · EXKIVITY · Enhertu · Epkinly · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Flexitouch Plus · Folotyn · Fulphila · GAZYVA · GILOTRIF · GIVLAARI · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · Jakafi · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NANOKNIFE · NINLARO · Neulasta · None · Nplate · Nubeqa · OCTAGAM · OGSIVEO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OXBRYTA · Oncology · Optune · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PGDX ELIO TISSUE COMPLETE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · QULIPTA · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · SYLVANT · SYNAGIS · Stimufend · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tibsovo · Trek · Trodelvy · Truqap · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
43
County median income
$83,765
Nearest hospital to ZIP centroid (approximate)
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Favaro is a mixed practice specialist, with above-average Medicare volume (top 3% in NC), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Favaro experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Favaro performed 20,400 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Favaro receive payments from pharmaceutical companies?
Yes. Dr. Favaro received a total of $29,422 from 100 companies across 709 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Favaro's costs compare to other hematology & oncology specialists in Charlotte?
Dr. Favaro's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Favaro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Charlotte
Browse hematology & oncology specialists in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NC
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NC
Which NC hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology